Company / PP&E per Share
Oric Pharmaceuticals, Inc. PP&E per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.03
FY2025
5-year range
$0.03 / $0.08
FY2021-FY2025
Trend
-34.4%
vs FY2024
Sector context
#136 of 191
Health Care
What the data says
At $0.03, Oric Pharmaceuticals, Inc.'s pp&e per share ranks #136 of 191 in the Health Care sector. PP&E per Share has declined for 3 consecutive years, from $0.08 in FY2022 to $0.03 in FY2025.
Based on SEC 10-K filings.
0.03 in FY2025 with a 5-year CAGR of -21.2%.
Declined from $0.06 to $0.03 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -30.5%
- 5-Year CAGR
- -21.2%
- 10-Year CAGR
- -
Sector benchmark
#136 of 191 in Health CareTop 71% of 191This company $0.03 Sector average $22.34
▼
-99.9% below sector average
Key checks
Key Insights
- Oric Pharmaceuticals, Inc.'s pp&e per share has declined for 3 consecutive years.
- In FY2025, pp&e per share decreased 34.4% year-over-year.
- Ranks #136 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.03 | -34.4% |
| FY2024 | $0.04 | -24.6% |
| FY2023 | $0.06 | -32.2% |
| FY2022 | $0.08 | +29.0% |
| FY2021 | $0.06 | -29.6% |
| FY2020 | $0.09 | -92.3% |
| FY2019 | $1.18 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026